Details for 2020177837
Up to date per 01.04.2026
Actions
Details for 2020177837
Granted/Registered
European Patent
21.10.2020 A
18.08.2021 B1
11.09.2012
US
201261699351 P
C07D 233/86 20060101AFI20200911BHEP
Owner
Medivation Prostate Therapeutics LLC66 Hudson Boulevard East New York, NY 10001-2192 US
Astellas Pharma Inc.2-5-1, Nihonbashi-Honcho Chuo-ku Tokyo 103-8411JP
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
LORENZ, Douglas Alanc/o Bend Research 64550 Research Road Bend, OR 97701US
KONAGURTHU, Sanjayc/o Bend Research 64550 Research Road Bend, OR 97701US
WALD, Randy J.c/o Bend Research 64550 Research Road Bend, OR 97701US
EVERETT, Jason A.c/o Bend Research 64550 Research Road Bend, OR 97701US
MATZ, Sheilac/o Medivation Prostate Therapeutics LLC 525 Market Street 36th Floor San Francisco, CA 94105US
TAKAISHI, Yuukic/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-Ku, Tokyo 103-8411JP
SAKAI, Toshiroc/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-Ku, Tokyo 103-8411JP
IRIE, Ryousukec/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-Ku, Tokyo 103-8411JP
OBA, Shinsukec/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-Ku, Tokyo 103-8411JP
TOYOTA, Hiroyasuc/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-Ku, Tokyo 103-8411JP
NISHIMURA, Kojic/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-Ku, Tokyo 103-8411JP
KANBAYASHI, Atsushic/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-Ku, Tokyo 103-8411JP
Information about Fees